Nils H. Van Creij
Innsbruck, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody-drug conjugates.
Journal: Cancer treatment reviews
Published: March 19, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.
Journal: BJU international
Published: March 03, 2026
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approach.
Journal: The journal of nutrition, health & aging
Published: November 27, 2025
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.
Journal: Clinical and translational medicine
Published: October 31, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma.
Journal: European urology oncology
Published: January 28, 2025
Repurposing Amiodarone for Bladder Cancer Treatment.
Journal: Cancer research communications
Published: August 21, 2024
Biological and therapeutic implications of sex hormone-related gene clustering in testicular cancer.
Biological and therapeutic implications of sex hormone-related gene clustering in testicular cancer.
Journal: Basic and clinical andrology
Published: August 06, 2024
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report.
Journal: Therapeutic advances in urology
Published: May 28, 2024
Upscaling Osteoclast Generation by Enhancing Macrophage Aggregation Using Hollow Microgels.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 23, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026